Skip to content

Culture-sensitive communication in pediatric oncology

Culture-sensitive communication in pediatric oncology - KuseKiO

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00029141
Enrollment
80
Registered
2022-06-13
Start date
2023-01-18
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

culture-sensitive communication

Interventions

Group 1: Doctor receives training on culture-sensitive communication Group 2: Doctor doesn't receive training on culture-sensitive communication

Sponsors

Klinik für Kinder-Onkologie, -Hämatologie und klinische Immunologie am Universitätsklinikum Düsseldorf
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0 Years to 17 Years

Inclusion criteria

Inclusion criteria: Pillar A: Included are underage patients and their families in life-changing conversations who are being treated at the Clinic for Paediatric Oncology, Haematology and Clinical Immunology and who have at least one of the following characteristics. 1: 1. the language predominantly spoken in the family is not German. 2. at least one parent, grandparent or great-grandparent of the child was not born in Germany (4th generation). The selection of cases should be as contrasting as possible in order to obtain a broad picture of different needs (on the part of doctors and families) and culturally conditioned aspects in A-E-P discussions. If possible, 10 families with different migration histories (with/without language barriers, grandchildren of guest workers, children/grandchildren of ethnic German immigrants, children from families who have recently fled, etc.) should be observed and interviewed in order to filter out commonalities and differences in needs and communication challenges in the context of the corresponding conversations. Pillar B: Included are underage patients and their families in life-changing conversations who are being treated at the Clinic for Paediatric Oncology, Haematology and Clinical Immunology and who have a 'migrant background' as defined by the Federal Statistical Office (i.e., the person themselves or at least one parent was not born with German citizenship).

Exclusion criteria

Exclusion criteria: Adult patients. For participation in the study, the consent of both the underaged patient and both legal guardians is required. Consent should be available for adolescents aged 14 years and older. A missing consent of one of the described participants is an exclusion criterion for the participation in the study. For the underage patients aged 8-13 years, consent is also sought, but it must be checked to what extent they can assess the significance and scope of the study. This must be decided on a case-by-case basis. For patients under 8 years of age, written consent is not required, but age-appropriate information and consent should be provided. In addition, the responsible physicians will have to decide on a case-by-case basis whether organizational, personal or situational factors stand in the way of accompanying the consultation.

Design outcomes

Primary

MeasureTime frame
The primary outcome is the difference in physician empathy as assessed by patient families between the physicians conducting the consultations with and without participation in the training. 2-4 weeks after the consultations, parents will be asked about physician empathy using the validated CARE scale.

Secondary

MeasureTime frame
As secondary outcome parameters, additional family-related scales, child-specific patient-related scales and the doctors' self-assessed intercultural competence will be collected via a questionnaire survey.

Countries

Germany

Contacts

Public ContactArndt Borkhardt

Klinik für Kinder-Onkologie, -Hämatologie und klinische Immunologie am Universitätsklinikum Düsseldorf

arndt.borkhardt@med.uni-duesseldorf.de02118116341

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026